Tze-Fang Wang

Tze-Fang Wang


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in Applied Nursing Research
Verified
Journal Article
Closed access
JGJong-Long Guo
Jong-Long Guo
TWTze-Fang Wang
Tze-Fang Wang
JLJ.Y. Liao
J.Y. Liao
CHChiu-Mieh Huang
Chiu-Mieh Huang

1 June 2015 in International Journal of Nursing Studies
Verified
Journal Article
Closed access
TWTze-Fang Wang
Tze-Fang Wang
CHChiu-Mieh Huang
Chiu-Mieh Huang
CCChyuan Chou
Chyuan Chou
SYShu Yu
Shu Yu

1 December 2014 in Medicine
Verified
Journal Article
Open access
TWTze-Fang Wang
Tze-Fang Wang
IJI-An Jen
I-An Jen
CCChyuan Chou
Chyuan Chou
YLYen-Ping Lei
Yen-Ping Lei
Epidemiologic studies have reported increased incidence, prevalence and acuity of periodontitis in adults with diabetes and some have also suggested that treating periodontal disease may improve glycemic control in diabetic patients. This meta-analysis was conducted to evaluate the effects of different periodontal therapies on metabolic control in patients with type 2 diabetes mellitus (T2DM) and periodontal disease. We searched the Medline, EMBASE and Cochrane Library (Central) databases up to January 2014 for relevant studies pertaining to periodontal treatments and glycemic control in adults with T2DM. The search terms were periodontal treatment/periodontal therapy, diabetes/diabetes mellitus, periodontitis/periodontal and glycemic control. The primary outcome measure taken from the included studies was glycated hemoglobin (HbA1c). We compared differences in patients' pre- and post-intervention HbA1c results between a treatment group receiving scaling and root planing (SRP) combined with administration of oral doxycycline (n=71) and controls receiving SRP alone or SRP plus placebo (n=72). Meta-analysis was performed using Comprehensive Meta Analysis software. Nineteen randomized controlled trials (RCTs) were identified. Four trials involving a total of 143 patients with T2DM and periodontal disease were determined to be eligible for analysis. Data of 1 study were not retained for meta-analysis because HbA1c results were recorded as median with IQR. Meta-analysis of the included 3 studies revealed no significant differences in HbA1c results between the periodontal treatment group (n=71) and control group (n=72) (HbA1c SMD=-0.238, 95% CI=-0.616 to 0.140; P=0.217). Systemic doxycycline added to SRP does not significantly improve metabolic control in patients with T2DM and chronic periodontitis. Current evidence is insufficient to support a significant association between periodontal therapy and metabolic control in this patient population. However, evidence suggests that periodontal therapy itself improves metabolic control and reinforces that T2DM is a risk factor for periodontitis.

14 January 2008 in Journal of Clinical Nursing
Verified
Journal Article
Closed access
PDF file
TWTze-Fang Wang
Tze-Fang Wang
CLChwen‐Hwa Lu
Chwen‐Hwa Lu
ICI‐Ju Chen
I‐Ju Chen
SYShu Yu
Shu Yu

1 January 2013 in International Journal for Equity in Health
Verified
Journal Article
Open access
PDF file
TWTze-Fang Wang
Tze-Fang Wang
LSLeiyu Shi
Leiyu Shi
XNXiaoyu Nie
Xiaoyu Nie
JZJinsheng Zhu
Jinsheng Zhu
To examine health care access disparities with regard to health status and presence of functional limitations, a common measure of disability and multimorbidity, after controlling for individual’s race/ethnicity, insurance status and income in the U.S. using the latest survey data.

1 February 2019 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
YKYun-Hua Kuo
Yun-Hua Kuo
TWTze-Fang Wang
Tze-Fang Wang
LLLi-Kuo Liu
Li-Kuo Liu
WLWei-Ju Lee
Wei-Ju Lee
LPLi-Ning Peng
Li-Ning Peng
LCLiang-Kung Chen
Liang-Kung Chen